Many tumors, including CLL, are characterized by increased number of T regulatory cells and expression of CD152 (CTLA4) in T cells with a correlation with advanced disease and adverse prognostic factors. Here, CTLA4 is linked to B-cell chronic lymphocytic leukemia.